Features of Circulating Parainfluenza Virus Required for Growth in Human Airway

• Main Authors: Laura M. Palermo, Manik Uppal, Lucy Skrabanek, Paul Zumbo, Soren Germer, Nora C. Toussaint, Bert K. Rima, Devra Huey, Stefan Niewiesk, Matteo Porotto, Anne Moscona
• Format: Article
• Language: English
• Published: American Society for Microbiology 2016-03-01
• Series: mBio
• Online Access: http://mbio.asm.org/cgi/content/full/7/2/e00235-16

Respiratory paramyxoviruses, including the highly prevalent human parainfluenza viruses, cause the majority of childhood croup, bronchiolitis, and pneumonia, yet there are currently no vaccines or effective treatments. Paramyxovirus research has relied on the study of laboratory-adapted strains of virus in immortalized cultured cell lines. We show that findings made in such systems about the receptor interaction and viral fusion requirements for entry and fitness—mediated by the receptor binding protein and the fusion protein—can be drastically different from the requirements for infection in vivo. Here we carried out whole-genome sequencing and genomic analysis of circulating human parainfluenza virus field strains to define functional and structural properties of proteins of circulating strains and to identify the genetic basis for properties that confer fitness in the field. The analysis of clinical strains suggests that the receptor binding-fusion molecule pairs of circulating viruses maintain a balance of properties that result in an inverse correlation between fusion in cultured cells and growth in vivo. Future analysis of entry mechanisms and inhibitory strategies for paramyxoviruses will benefit from considering the properties of viruses that are fit to infect humans, since a focus on viruses that have adapted to laboratory work provides a distinctly different picture of the requirements for the entry step of infection.